Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

UK pharma continues to approach social media cautiously

Novartis UK becomes the latest in a trickle of firms to join Twitter

- PMLiVE

Janssen files Stelara follow-up guselkumab in Europe

Trial data shows J&J’s drug is more effective in treating psoriasis than AbbVie’s Humira

- PMLiVE

GSK set for 2017 European rollout of med device asthma app

Updated version of the MyAsthma iPhone app is firm's first Class 1 med device

Actelion HQ Switzerland

Resurgent Actelion catches J&J’s eye

Confirms talks of possible take over after Uptravi sees ‘outstanding’ sales

- PMLiVE

Branding Science adds to senior management team

Jon Chandler joins the market research consultancy

- PMLiVE

Real-world evidence

Investigating the sources of evidence as best practice moves from being knowledge-based to evidence-based

- PMLiVE

Takeda gets EU green light for oral myeloma drug

Ninlaro first oral proteasome inhibitor to be registered in Europe

- PMLiVE

GSK starts late-stage trials of daprodustat

Drug hopes to treat anaemia caused by chronic kidney disease

- PMLiVE

Healthcare and the artificial intelligence revolution

How technologists and healthcare professionals are working together to improve patient outcomes

- PMLiVE

Dr Irina Antonijevic joins vasopharm

Becomes chief medical officer of the cerebrovascular specialist

- PMLiVE

Changing behaviour: putting theory into practice

Directions in behaviour change: From translating the theory into practice to looking at its design implications and beyond, we put behavioural change under the spotlight

- PMLiVE

NICE U-turn sees Celgene’s Imnovid backed for multiple myeloma

New data and a discount swayed the cost-effectiveness body

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links